Atalanta Sosnoff Capital’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$320K Sell
4,092
-324
-7% -$26.1K 0.01% 97
2026
Q1
$383K Sell
4,416
-29
-0.7% -$2.78K 0.01% 91
2025
Q4
$427K Sell
4,445
-144
-3% -$14K 0.01% 77
2025
Q3
$437K Sell
4,589
-100
-2% -$9.19K 0.01% 81
2025
Q2
$409K Buy
4,689
+166
+4% +$14.1K 0.01% 79
2025
Q1
$406K Buy
4,523
+681
+18% +$60.9K 0.01% 76
2024
Q4
$307K Buy
3,842
+303
+9% +$26.2K 0.01% 84
2024
Q3
$319K Hold
3,539
0.01% 87
2024
Q2
$279K Sell
3,539
-139
-4% -$11.4K 0.01% 79
2024
Q1
$321K Buy
+3,678
New +$314K 0.01% 85
2023
Q4
Sell
-654,924
Closed -$51.3M 99
2023
Q3
$51.3M Sell
654,924
-15,461
-2% -$1.29M 1.52% 24
2023
Q2
$59.1M Buy
670,385
+33,247
+5% +$2.86M 1.6% 19
2023
Q1
$51.4M Sell
637,138
-14,506
-2% -$1.18M 1.49% 26
2022
Q4
$50.6M Sell
651,644
-68,524
-10% -$5.55M 1.56% 24
2022
Q3
$58.2M Sell
720,168
-15,961
-2% -$1.43M 1.84% 22
2022
Q2
$66.1M Sell
736,129
-29,323
-4% -$2.97M 1.99% 16
2022
Q1
$84.9M Buy
765,452
+189,034
+33% +$20M 1.99% 12
2021
Q4
$59.6M Sell
576,418
-26,629
-4% -$3.08M 1.29% 26
2021
Q3
$75.6M Sell
603,047
-2,591
-0.4% -$335K 1.77% 19
2021
Q2
$75.2M Buy
605,638
+5,402
+0.9% +$678K 1.74% 21
2021
Q1
$70.9M Sell
600,236
-586
-0.1% -$68.7K 1.75% 18
2020
Q4
$70.4M Buy
600,822
+374,321
+165% +$41.2M 1.8% 20
2020
Q3
$23.5M Sell
226,501
-3,501
-2% -$352K 0.67% 52
2020
Q2
$21.1M Buy
230,002
+180,729
+367% +$17.3M 0.64% 50
2020
Q1
$4.44M Buy
+49,273
New +$5.24M 0.16% 71
2019
Q2
Sell
-521,176
Closed -$47.5M 101
2019
Q1
$47.5M Buy
521,176
+2,027
+0.4% +$181K 1.48% 30
2018
Q4
$47.2M Buy
519,149
+158,182
+44% +$14.8M 1.72% 23
2018
Q3
$35.5M Buy
+360,967
New +$33.4M 1.06% 39
2016
Q4
Sell
-337,307
Closed -$29.1M 109
2016
Q3
$29.1M Sell
337,307
-27,519
-8% -$2.4M 1.01% 43
2016
Q2
$31.7M Sell
364,826
-21,535
-6% -$1.74M 1.06% 37
2016
Q1
$29M Sell
386,361
-50,015
-11% -$3.77M 0.91% 45
2015
Q4
$33.6M Sell
436,376
-183,943
-30% -$13.8M 1% 44
2015
Q3
$41.5M Sell
620,319
-74,883
-11% -$5.52M 1.33% 34
2015
Q2
$51.5M Sell
695,202
-374,676
-35% -$28.6M 1.41% 32
2015
Q1
$83.4M Sell
1,069,878
-442,392
-29% -$33.5M 2.22% 12
2014
Q4
$109M Buy
1,512,270
+227,776
+18% +$15.8M 2.69% 8
2014
Q3
$79.6M Buy
1,284,494
+368,101
+40% +$23.4M 1.97% 25
2014
Q2
$58.4M Buy
+916,393
New +$55.7M 1.28% 34

Other funds holding MDT

Atalanta Sosnoff Capital's MDT Position: Q2 2026 in Review

Atalanta Sosnoff Capital reduced its Medtronic (MDT) stake by 7.3% in Q2 2026, selling an estimated $26.1K and leaving 4,092 shares worth $320K. The position accounts for 0.01% of the portfolio, ranked #97.

Atalanta Sosnoff Capital first reported a position in MDT in Q2 2014 and has held it in 38 quarters since. The position peaked at $109M in Q4 2014. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Atalanta Sosnoff Capital held 4,092 shares of Medtronic worth $320K as of Q2 2026.
  • Atalanta Sosnoff Capital sold 324 Medtronic shares in Q2 2026, an estimated $26.1K.
  • Medtronic made up 0.01% of Atalanta Sosnoff Capital's portfolio in Q2 2026, its #97 holding.
  • Atalanta Sosnoff Capital first reported a position in Medtronic in Q2 2014 and has held it in 38 quarters since.
  • Atalanta Sosnoff Capital's Medtronic position peaked at $109M in Q4 2014.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Atalanta Sosnoff Capital's 13F filing for Q2 2026, filed 12 Aug 2026.